about
Steroid withdrawal 3 months after liver transplantation--does FK 506 confer any advantage over cyclosporin?Referral of patients with primary biliary cirrhosis for liver transplantation.Cardiovascular morbidity and mortality after orthotopic liver transplantation.Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence.UK experience of liver transplantation for erythropoietic protoporphyria.Quality control of the European Liver Transplant Registry: results of audit visits to the contributing centers.Patterns of alcohol consumption after liver transplantation.Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome.Liver resection for colorectal metastases.Liver transplantation for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosis.Factors influencing blood transfusion during adult liver transplantation.Haematological malignancies presenting with acute liver injury: a single-centre experience.Aetiology and outcome of acute liver failure.Pulmonary thromboembolism in liver transplantation: a retrospective review of the first 25 years.Increasing the donor pool: consideration of prehospital cardiac arrest in controlled donation after circulatory death for liver transplantation.Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales.Risk factors for recurrent primary sclerosing cholangitis after liver transplantation.Neutrophil-to-lymphocyte ratio predicts mortality in patients listed for liver transplantation.Reticulocyte count and hemoglobin concentration predict survival in candidates for liver transplantation.Viral hepatitis in Nigeria--sickle-cell disease and commercial blood donors.Outcomes of liver transplantation for paracetamol (acetaminophen)-induced hepatic failure.Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation.Influence of ischemia-reperfusion injury on rejection after liver transplantation.Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism.Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation.Fluconazole prophylaxis for high-risk liver transplant recipients.HLA matching in liver transplantation: a retrospective analysis.Outcomes following liver transplantation for seronegative acute liver failure: experience during a 12-year period with more than 100 patients.Hepatic ischemia reperfusion injury is associated with acute kidney injury following donation after brain death liver transplantation.Ten-year results of a randomised prospective study of FK506 versus cyclosporine in management of primary orthotopic liver transplantation.Late acute liver allograft rejection; a study of its natural history and graft survival in the current era.Morphometric study of renal transplant biopsies using an antibody to brush borders.Chronic kidney disease after nonrenal solid organ transplantation: a histological assessment and utility of chronic allograft damage index scoring.A case-controlled study of the safety and efficacy of transjugular intrahepatic portosystemic shunts after liver transplantation.Surgical strategy in liver transplantation for polycystic liver disease.Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation.Outcomes after identical and compatible orthotopic liver transplantation for fulminant hepatic failure: a single center experience in UK.Morphometric correlates of renal excretory function.Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus.
P50
Q34196928-7042EC43-9FB3-47B7-97C2-95FA82BE776FQ34392964-9D38220B-674F-48DF-B49D-8ECE04F69DBBQ34581979-C2C5395D-C2AC-4D28-8ABE-34C928FAD874Q34609958-7A5B14F1-5CDA-4C6F-B3AC-0AF0CD36A6CAQ35004685-13F9A0E9-C7B1-46FF-B1E9-9BE52900B962Q35164122-2FCDB80F-7CBA-4E92-9741-0A0EED71299EQ35351567-0DC8D8CD-D2B6-499F-8668-F0B69CE46576Q35760502-6156D1EF-31AA-49B8-834A-C37BBC573C56Q35970609-9446FF67-B3F2-42AF-8728-1395CD761CEEQ36319508-1D0ED07D-D660-41F4-9121-052683C796A4Q36814445-76F5D2E6-5FC1-4CBC-ADE1-56745DC2A2F8Q37277437-5D087427-8CB2-4B71-B298-B8072033799BQ37343433-9C458FEB-CD3F-436E-A750-7337504BB4C6Q37760278-1F9A110E-2387-48B7-A732-4808F451417CQ38154246-04AB3916-D63A-49FE-B659-06C16AB4FFFEQ38471669-B4E1D75E-E951-4303-9572-AD4FA65D2EA9Q40723811-C63CE014-0C76-431E-8E6B-3003DBD0F2C1Q41734066-20604845-8E7A-4BED-9491-3607BE0C7460Q42228173-A7AECEA4-700C-448E-A23E-9A14C0D6E39BQ43041345-ED27EB01-2A19-4C80-AD4D-184781C37651Q43269343-02515631-2BA8-4EFE-8423-C7858031C0C9Q43281064-55A7C39F-DB4F-4BEC-A984-0939F7560A2BQ43499152-70B928E9-C7CF-4FEC-BAB8-D1C60D5E061BQ43604919-8D24F93B-E682-45CC-95D5-F29D9B221922Q43666890-D14CAE8B-C2E9-4343-A96A-6EE4EF41F04BQ43733935-0AB81D44-59A8-4272-B716-905CF24AE8FFQ43834744-4804D56D-E0C2-400A-A2EC-346978BA98C2Q43835620-11CFA765-A131-479E-B7B7-152DFBCA73ACQ43865439-E1E5704D-E1BB-40DE-A215-63558701DE74Q44101286-D48FC1F6-F494-4A88-839D-9ED4CDD9797CQ44466074-952E5078-DD04-4DEF-B7E4-169D8C0D8FFDQ44471310-D5318049-C2BA-4B46-B1E2-40D509D1F68DQ44477591-FDF348F7-CD70-4C6C-B469-C0DFA5180D95Q44785114-348A6C8B-014A-4550-BD54-3ECC4AAF4792Q44807119-198B1F40-5871-43B9-AE61-15FB8228BF23Q44817502-AABCC4E4-294E-4949-8672-5245BD04F041Q44925956-0196D670-FDEE-4714-9E15-70609C27FBCAQ44937096-517A6271-E56A-4037-8FDA-4C3EC7601639Q45196853-A8FD9D83-9D0E-4805-8AA9-CF9F605A7F2CQ45420722-3995DC47-A597-409C-958D-A01A04588B8F
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Bridget Gunson
@ast
Bridget Gunson
@en
Bridget Gunson
@es
Bridget Gunson
@nl
Bridget Gunson
@sl
type
label
Bridget Gunson
@ast
Bridget Gunson
@en
Bridget Gunson
@es
Bridget Gunson
@nl
Bridget Gunson
@sl
prefLabel
Bridget Gunson
@ast
Bridget Gunson
@en
Bridget Gunson
@es
Bridget Gunson
@nl
Bridget Gunson
@sl
P106
P21
P31
P496
0000-0001-6149-9915